Coumadin anticoagulent

Coumadin is a well-known anticoagulant medication, commonly referred to as a blood thinner, used to prevent and treat blood clots. The brand was originally developed based on research at the University of Wisconsin-Madison involving the discovery of dicumarol. The pharmaceutical name 'Warfarin' (the active ingredient) is actually an acronym derived from the Wisconsin Alumni Research Foundation (WARF).

Manufacturing for the brand-name Coumadin primarily occurs in the United States, though global supply chains may involve various production sites for generic versions. The brand was historically associated with DuPont Pharmaceuticals, which was eventually acquired by Bristol-Myers Squibb. Today, Bristol-Myers Squibb remains the ultimate owner of the brand name Coumadin, managing its distribution as a leading global biopharmaceutical company specialized in oncology, hematology, and cardiovascular diseases.